Literature DB >> 15931653

Reliability of Group Health Cooperative automated pharmacy data by drug benefit status.

Denise M Boudreau1, Mark P Doescher, Barry G Saver, J Elizabeth Jackson, Paul A Fishman.   

Abstract

PURPOSE: Evaluate the reliability of health plan pharmacy records in determining medication use among seniors with and without a drug benefit.
METHODS: Subjects included 3610 seniors, enrolled in Group Health Cooperative's Medicare (GHC) + Choice program during 1998-1999, receiving care in an integrated group practice (IGP), and diagnosed with one or more of four chronic conditions (hypertension, diabetes, congestive heart failure, and coronary artery disease). We compared pharmacy records to self-reported medication use for antidepressant, antihypertensive, acid suppressant, cardiac, diabetic, hormone, and lipid lowering drugs.
RESULTS: Agreement between pharmacy records and self-report was substantial to almost perfect (prevalence-adjusted and bias-adjusted kappa (PABAK) range: 0.69 for antihypertensives to 0.95 for cardiac agents) among seniors with a drug benefit. Agreement was slightly less for seniors without a drug benefit (PABAK range: 0.51 for antihypertensives to 0.92 for cardiac agents) and differences varied by drug class. Among seniors without a benefit, the prevalence of medication use was lower when based on pharmacy records than when based on self-report for all medication classes of interest.
CONCLUSIONS: While GHC may not be representative of all health plans, our study indicates that health plan pharmacy records are a reliable source of data for seniors receiving care within an IGP. However, the reliability of pharmacy records appears better among seniors with a drug benefit. Researchers should consider factors such as drug benefit status when conducting studies using pharmacy data. More studies are needed in different populations and delivery systems, as well as over varied types of drug benefits. Copyright (c) 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2005        PMID: 15931653     DOI: 10.1002/pds.1119

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  17 in total

1.  Histamine-2 receptor antagonist use and incident dementia in an older cohort.

Authors:  Shelly L Gray; Rod Walker; Sascha Dublin; Sebastien Haneuse; Paul K Crane; John C S Breitner; James Bowen; Wayne McCormick; Eric B Larson
Journal:  J Am Geriatr Soc       Date:  2011-02       Impact factor: 5.562

2.  A systematic review of methods for determining cross-sectional active medications using pharmacy databases.

Authors:  Timothy S Anderson; Edison Xu; Evans Whitaker; Michael A Steinman
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-02-13       Impact factor: 2.890

3.  Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study.

Authors:  Sascha Dublin; Rod L Walker; Michael L Jackson; Jennifer C Nelson; Noel S Weiss; Lisa A Jackson
Journal:  Pharmacoepidemiol Drug Saf       Date:  2010-08       Impact factor: 2.890

4.  Breast cancer recurrence in relation to antidepressant use.

Authors:  Jessica Chubak; Erin J A Bowles; Onchee Yu; Diana S M Buist; Monica Fujii; Denise M Boudreau
Journal:  Cancer Causes Control       Date:  2015-10-30       Impact factor: 2.506

5.  Formulations of hormone therapy and risk of Parkinson's disease.

Authors:  Jessica I Lundin; Thanh G N Ton; Andrea Z LaCroix; W T Longstreth; Gary M Franklin; Phillip D Swanson; Terri Smith-Weller; Brad A Racette; Harvey Checkoway
Journal:  Mov Disord       Date:  2014-09-25       Impact factor: 10.338

6.  Patient-reported care coordination: associations with primary care continuity and specialty care use.

Authors:  David T Liss; Jessica Chubak; Melissa L Anderson; Kathleen W Saunders; Leah Tuzzio; Robert J Reid
Journal:  Ann Fam Med       Date:  2011 Jul-Aug       Impact factor: 5.166

7.  A comparison of self-reported oral contraceptive use and automated pharmacy data in perimenopausal and early postmenopausal women.

Authors:  Leslie Spangler; Laura E Ichikawa; Rebecca A Hubbard; Belinda Operskalski; Andrea Z LaCroix; Susan M Ott; Delia Scholes
Journal:  Ann Epidemiol       Date:  2014-10-16       Impact factor: 3.797

8.  Cost of breast-related care in the year following false positive screening mammograms.

Authors:  Jessica Chubak; Denise M Boudreau; Paul A Fishman; Joann G Elmore
Journal:  Med Care       Date:  2010-09       Impact factor: 2.983

9.  Health care utilization and costs associated with childhood abuse.

Authors:  Amy E Bonomi; Melissa L Anderson; Frederick P Rivara; Elizabeth A Cannon; Paul A Fishman; David Carrell; Robert J Reid; Robert S Thompson
Journal:  J Gen Intern Med       Date:  2008-01-19       Impact factor: 5.128

10.  Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk.

Authors:  P A Newcomb; A Trentham-Dietz; J M Hampton
Journal:  Br J Cancer       Date:  2010-02-16       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.